InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Lachey Jennifer, Directeur Scientifique. Director active across 1 company, notably Keros Therapeutics, Inc.. Aggregated, 17 reports have been recorded. Activity tracked since 11 May 2021. The latest transaction was filed on 15 July 2022 (Levée d'options). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Lachey Jennifer
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations17 total
46,034 shares@ US$0.3028.9% of flowCommon StockSEC:0001209191-22-042573:0
1,916 shares@ US$0.301.2% of flowCommon StockSEC:0001209191-22-042253:0
9,400 shares@ US$0.300.0004% mcap8.1% of flowCommon StockSEC:0001209191-22-036800:0
5,300 shares@ US$0.300.0002% mcap4.5% of flowCommon StockSEC:0001209191-22-028889:0
5,300 shares@ US$0.300.0002% mcap4.4% of flowCommon StockSEC:0001209191-22-024290:0
7,950 shares@ US$0.300.0004% mcap6.5% of flowCommon StockSEC:0001209191-22-023494:0
2,650 shares@ US$0.300.0001% mcap2.2% of flowCommon StockSEC:0001209191-22-018836:0
2,650 shares@ US$0.300.0001% mcap2.1% of flowCommon StockSEC:0001209191-22-009792:0
2,650 shares@ US$0.302.0% of flowCommon StockSEC:0001209191-22-003198:0
2,650 shares@ US$0.302.0% of flowCommon StockSEC:0001209191-22-002416:0
1,915 shares@ US$0.301.4% of flowCommon StockSEC:0001209191-21-069767:0
15,900 shares@ US$0.3011.5% of flowCommon StockSEC:0001209191-21-064218:0
10,600 shares@ US$0.307.7% of flowCommon StockSEC:0001209191-21-063210:0
1,293 shares@ US$0.300.9% of flowCommon StockSEC:0001209191-21-052271:0
6,500 shares@ US$0.304.6% of flowCommon StockSEC:0001209191-21-043392:0
2,650 shares@ US$0.301.8% of flowCommon StockSEC:0001209191-21-040651:0
2,650 shares@ US$0.301.8% of flowCommon StockSEC:0001209191-21-032358:0
17 of 17 declarations
About Lachey Jennifer
Lachey Jennifer is Chief Scientific Officer at Keros Therapeutics, Inc. She has 17 filings in total, and across the recent filings available, the period runs from 2021-05-13 to 2022-07-19. The modal transaction nature is Option exercise, with sum_buy_eur at 0 and sum_sell_eur at 0 in this sample.
